Studies suggest a negative correlation between uromodulins and triglycerides (TG) alongside a positive correlation with high-density lipoprotein cholesterol (HDL-C), indicating their potential in modulating lipid metabolism and reducing CHD risk (112, 113). The gene discussed is UMOD; the disease is coronary artery disorder.